Guided Therapeutics, Inc. Share Price
Stocks
GTHP
US40171F5017
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2800 USD | +14.29% |
|
+16.67% | -48.15% |
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| 05-15 | Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 27.03M 23.63M 21.72M 20.24M 38.39M 2.57B 38.98M 261M 101M 1.27B 101M 99.28M 4.36B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 29.91M 26.14M 24.03M 22.4M 42.48M 2.85B 43.12M 288M 112M 1.4B 112M 110M 4.82B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +14.29% | ||
| 1 week | +16.67% | ||
| Current month | +16.67% | ||
| 1 month | +22.81% | ||
| 3 months | +16.67% | ||
| 6 months | -48.15% | ||
| Current year | -48.15% |
| 1 week | 0.2 | 0.28 | |
| 1 month | 0.18 | 0.34 | |
| Current year | 0.17 | 0.54 | |
| 1 year | 0.12 | 0.54 | |
| 3 years | 0.06 | 0.54 | |
| 5 years | 0.06 | 0.78 | |
| 10 years | 0.02 | 5,760 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 05/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 01/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 30/11/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 09/04/2006 |
Michael James
CHM | Chairman | 67 | 30/09/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-09 | Others | Director | 466,991 | 0.5586% | ||
| 03-09 | Others | Director | 10 | 0.9747% | ||
| 03-09 | Free | Chairman | 110,000 | 0.1316% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.29% | +16.67% | +5.46% | +24.44% | 27.03M | ||
| +1.97% | +2.03% | +21.92% | +0.83% | 195B | ||
| +5.87% | +5.27% | -21.76% | +26.78% | 151B | ||
| +2.17% | +0.89% | -2.59% | -16.42% | 140B | ||
| +4.83% | +2.06% | -56.73% | -15.69% | 67.09B | ||
| +2.59% | +3.95% | +22.89% | +3.15% | 54.34B | ||
| +0.03% | +2.19% | -25.48% | -31.00% | 44.64B | ||
| -2.02% | -3.91% | +7.67% | +9.53% | 36.91B | ||
| +0.31% | +1.30% | +8.30% | +43.25% | 37.24B | ||
| +1.09% | -0.30% | -13.81% | -18.74% | 29.82B | ||
| Average | +3.11% | +2.73% | -5.41% | +2.61% | 75.56B | |
| Weighted average by Cap. | +2.66% | +3.35% | -3.84% | +1.38% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.12K 5.62K 5.24K 9.94K 666K 10.09K 67.51K 26.25K 328K 26.28K 25.71K 1.13M | 767K 671K 616K 574K 1.09M 73.03M 1.11M 7.4M 2.88M 35.9M 2.88M 2.82M 124M |
| Net income | -2.42M -2.11M -1.94M -1.81M -3.43M -230M -3.49M -23.31M -9.06M -113M -9.07M -8.88M -390M | -3.2M -2.79M -2.57M -2.39M -4.54M -304M -4.61M -30.82M -11.98M -150M -12M -11.74M -515M |
| Net Debt | 1.77M 1.55M 1.42M 1.33M 2.52M 169M 2.55M 17.08M 6.64M 82.89M 6.65M 6.5M 286M | 2.88M 2.51M 2.31M 2.15M 4.08M 274M 4.15M 27.74M 10.78M 135M 10.8M 10.56M 464M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | US$0.2800 | +14.29% | 5,570 |
| 01/07/26 | US$0.2450 | +2.08% | 11,276 |
| 30/06/26 | US$0.2400 | +19.94% | 200 |
| 29/06/26 | US$0.2001 | -16.62% | 3,771 |
| 26/06/26 | US$0.2400 | -7.69% | 106 |
- Stock Market
- Stocks
- GTHP Stock
Select your edition
All financial news and data tailored to specific country editions
















